OMER

OMEROS CORP

Pharmaceuticals · Pharmaceuticals

$236.10 sample

-1.69 (-0.71%) 1D

Market cap

$1.08T

Price as of

2026-10-04

Latest filing

8-K · 2026-09-21

Alerts

8

Price$236.10 +13.04% 3M daily closessample

240.76207.10

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider sell: Director
Sep 21SEC8-K filed: material event
Sep 16INSInsider sell: EVP, Operations
Sep 07INSInsider sell: General Counsel
Sep 02INSInsider sell: Director
Aug 26INSInsider buy: Chief Executive Officer
Aug 18INSInsider sell: Chief Executive Officer
Aug 11INSInsider buy: Chief Executive Officer

Sign up to see the real OMER record →

Company facts

SEC EDGAR registration

Name: OMEROS CORP
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Smart-money score: -53sample, -100 to +100
Reporting currency: USD

Who is positioning in OMER

sample

Insiders: 22 insider transactions over 90 days, net selling, $320.2M
Congress: No member trades over 90 days
Institutions · 13F: 11 funds hold $14.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$61.0B +20.0% y/y

Q4 2024Q3 2026

Inventory$37.2B +12.8% y/y

Q4 2024Q3 2026

Accounts receivable$25.8B +11.5% y/y

Q4 2024Q3 2026

Total debt$74.3B +11.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.05T +1.1% 3M
Sample peer B: $399.0B -11.4% 3M
Sample peer C: $155.1B -4.1% 3M
Sample peer D: $317.0B +2.9% 3M
Sample peer E: $134.2B -12.1% 3M